Pennisi A, Li X, Ling W. et al. The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo. Am J Hematol 2009; 84 (1): 6-14
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.